Design Therapeutics
(NASDAQ) DSGN
Design Therapeutics Financials at a Glance
Market Cap
$692.58M
Revenue (TTM)
$0.00
Net Income (TTM)
$69.79M
EPS (TTM)
$-1.22
P/E Ratio
-9.22
Dividend
$0.00
Beta (Volatility)
1.58 (High)
Dividend
$0.00
Beta (Volatility)
1.58 (High)
Price
$11.24
Volume
9,074
Open
$10.54
Price
$11.24
Volume
9,074
Open
$10.54
Previous Close
$11.24
Daily Range
$10.54 - $11.29
52-Week Range
$2.60 - $11.30
Dividend
$0.00
Beta (Volatility)
1.58 (High)
Price
$11.24
Volume
9,074
Open
$10.54
Previous Close
$11.24
Daily Range
$10.54 - $11.29
52-Week Range
$2.60 - $11.30
DSGN News
DSGN: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Design Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
124
CEO
Pratik Shah, PhD, MBA
Website
www.designtx.comHeadquarters
Carlsbad, CA 92011, US
DSGN Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-31%
Return on Capital
-37%
Return on Assets
-31%
Earnings Yield
-10.85%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$692.58M
Shares Outstanding
61.67M
Volume
9.07K
Short Interest
0.00%
Avg. Volume
267.74K
Financials (TTM)
Gross Profit
$622.00K
Operating Income
$79.47M
EBITDA
$78.84M
Operating Cash Flow
$54.36M
Capital Expenditure
$193.00K
Free Cash Flow
$54.55M
Cash & ST Invst.
$219.84M
Total Debt
$645.00K
Design Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$14.74M
N/A
Gross Margin
0.00%
N/A
Market Cap
$692.58M
N/A
Market Cap/Employee
$12.37M
N/A
Employees
56
N/A
Net Income
$16.00M
-17.2%
EBITDA
$18.01M
-8.9%
Quarterly Fundamentals
Net Cash
$219.20M
-9.8%
Accounts Receivable
$1.68M
+32.8%
Inventory
$0.00
N/A
Long Term Debt
$645.00K
-58.0%
Short Term Debt
$0.00
-100.0%
Return on Assets
-30.85%
N/A
Return on Invested Capital
-37.28%
N/A
Free Cash Flow
$12.00M
-21.7%
Operating Cash Flow
$11.97M
-21.4%